AmerisourceBergen Board Looks To Ax Opioid Derivative Suit
AmerisourceBergen Corp.'s board of directors is asking a Delaware federal court to throw out claims by shareholders that it ignored "red flags" that opioids the company produced were being diverted, saying...To view the full article, register now.
Already a subscriber? Click here to view full article